Curaleaf (OTCMKTS:CURLF) Issues Earnings Results

Curaleaf (OTCMKTS:CURLF) issued its quarterly earnings data on Thursday. The company reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.08) by $0.03, Zacks reports. Curaleaf had a negative return on equity of 15.57% and a negative net margin of 19.50%.

Curaleaf Stock Performance

CURLF traded down $0.05 during trading on Thursday, hitting $2.43. 7,223,622 shares of the company traded hands, compared to its average volume of 563,108. Curaleaf has a one year low of $0.68 and a one year high of $5.05. The stock’s fifty day moving average is $2.53 and its 200 day moving average is $2.71. The company has a quick ratio of 0.71, a current ratio of 1.47 and a debt-to-equity ratio of 0.96. The firm has a market cap of $1.65 billion, a P/E ratio of -7.60 and a beta of 0.74.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the stock. Zacks Research raised shares of Curaleaf from a “strong sell” rating to a “hold” rating in a report on Thursday, January 1st. Alliance Global Partners reissued a “buy” rating on shares of Curaleaf in a research report on Monday, December 22nd. Finally, ATB Cormark Capital Markets raised shares of Curaleaf to an “outperform” rating in a research report on Tuesday, December 2nd. Two research analysts have rated the stock with a Strong Buy rating, one has given a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy”.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.